Assessing current and potential IP value—learn from the best!

Early stage value relies heavily on IP. Yet, IP valuation is tricky--there are no comparables in the market, discount rates are not directly observable, competitors can attack protections, and the commercial market may be less than expected.

While correctly assessing IP value can lead to remarkable shareholder wealth creation, incorrect valuation can be very costly. In today’s environment of open innovation and technology partnerships, this is particularly true. A two-day workshop March 6-7 by Mike Pellegrino can provide you with realistic guidelines to correctly value your organization’s early stage technologies. This course provides detailed steps to:

  • Identify key sources of value.
  • Decide which valuation approach to use for different situations: cost, market, income.
  • Correctly assess market potential, value proposition.
  • Prioritize opportunities—invest or divest appropriately to maximize ROI.
  • Establish ownership, license, and/or partnership deals.
  • Protect and leverage your firm’s intellectual property.
  • Strengthen your patent and product portfolio.
Pellegrino, who is author of BVR’s Guide to Intellectual Property Valuation and one of the world's foremost experts on how to value early stage technologies, will be leading this hands-on session in San Jose, Calif. Through a combination of methods, case examples, and hands-on exercises, you will learn to take the guesswork out of this critical activity.

Registration fee is $1,695/person before Jan. 31 ($1,995 thereafter). Fee includes workshop materials, luncheons, refreshment breaks, reception, and post-workshop follow-up. Group discount: Teams of three or more that register together may deduct $100 each from the fee. To register, click here.

And--for those appraisers concerned about the AICPA Exposure Draft on IPR&D, you can hear from one of the committee members next week:  The State of IPR&D: Examining the AICPA Exposure Draft, February 9, featuring David Dufendach, CPA/ABV, ASA (Grant Thornton LLP).